Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    19547919 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment
Conditions: Extragonadal Germ Cell Tumor;   Ovarian Cancer;   Teratoma;   Testicular Germ Cell Tumor
Intervention: Drug: sunitinib malate
To Top

† Indicates status has not been verified in more than two years